External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group

Monica Mangoni; Carlo Gobitti; Rosa Autorino; Lorenzo Cerizza; Carlo Furlan; Renzo Mazzarotto; Fabio Monari; Gabriele Simontacchi; Federica Vianello; Michela Basso; Giuseppe Zanirato Rambaldi; Elvio Russi; Luca Tagliaferri

doi:10.5301/tj.5000532

External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group

Monica Mangoni, Carlo Gobitti, Rosa Autorino, Lorenzo Cerizza, Carlo Furlan, Renzo Mazzarotto, Fabio Monari, Gabriele Simontacchi, Federica Vianello, Michela Basso, Giuseppe Zanirato Rambaldi, Elvio Russi, Luca Tagliaferri

Research output: Contribution to journal › Review article

Abstract

The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the "Radioterapia Metabolica" Group of the Italian Radiation Oncology Association.

Original language	English
Pages (from-to)	114-123
Number of pages	10
Journal	Tumori
Volume	103
Issue number	2
DOIs	https://doi.org/10.5301/tj.5000532
Publication status	Published - Mar 1 2017

Keywords

Anaplastic thyroid carcinoma
External beam radiotherapy
Follicular thyroid carcinoma
Medullary thyroid carcinoma
Papillary thyroid carcinoma
Radiometabolic therapy

ASJC Scopus subject areas

Medicine(all)
Oncology
Cancer Research

Access to Document

10.5301/tj.5000532

Fingerprint Dive into the research topics of 'External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group'. Together they form a unique fingerprint.

Cite this

Mangoni, M., Gobitti, C., Autorino, R., Cerizza, L., Furlan, C., Mazzarotto, R., Monari, F., Simontacchi, G., Vianello, F., Basso, M., Rambaldi, G. Z., Russi, E., & Tagliaferri, L. (2017). External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group. Tumori, 103(2), 114-123. https://doi.org/10.5301/tj.5000532

External beam radiotherapy in thyroid carcinoma : Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group. / Mangoni, Monica; Gobitti, Carlo; Autorino, Rosa; Cerizza, Lorenzo; Furlan, Carlo; Mazzarotto, Renzo; Monari, Fabio; Simontacchi, Gabriele; Vianello, Federica ; Basso, Michela; Rambaldi, Giuseppe Zanirato; Russi, Elvio; Tagliaferri, Luca.

In: Tumori, Vol. 103, No. 2, 01.03.2017, p. 114-123.

Research output: Contribution to journal › Review article

Mangoni, M, Gobitti, C, Autorino, R, Cerizza, L, Furlan, C, Mazzarotto, R, Monari, F, Simontacchi, G, Vianello, F , Basso, M, Rambaldi, GZ, Russi, E & Tagliaferri, L 2017, 'External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group', Tumori, vol. 103, no. 2, pp. 114-123. https://doi.org/10.5301/tj.5000532

Mangoni, Monica ; Gobitti, Carlo ; Autorino, Rosa ; Cerizza, Lorenzo ; Furlan, Carlo ; Mazzarotto, Renzo ; Monari, Fabio ; Simontacchi, Gabriele ; Vianello, Federica ; Basso, Michela ; Rambaldi, Giuseppe Zanirato ; Russi, Elvio ; Tagliaferri, Luca. / External beam radiotherapy in thyroid carcinoma : Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group. In: Tumori. 2017 ; Vol. 103, No. 2. pp. 114-123.

@article{b9d6be7440cf44528e3bfcbc0729fe90,

title = "External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO {"}Radioterapia Metabolica{"} Group",

abstract = "The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the {"}Radioterapia Metabolica{"} Group of the Italian Radiation Oncology Association.",

keywords = "Anaplastic thyroid carcinoma, External beam radiotherapy, Follicular thyroid carcinoma, Medullary thyroid carcinoma, Papillary thyroid carcinoma, Radiometabolic therapy",

author = "Monica Mangoni and Carlo Gobitti and Rosa Autorino and Lorenzo Cerizza and Carlo Furlan and Renzo Mazzarotto and Fabio Monari and Gabriele Simontacchi and Federica Vianello and Michela Basso and Rambaldi, {Giuseppe Zanirato} and Elvio Russi and Luca Tagliaferri",

year = "2017",

month = mar,

day = "1",

doi = "10.5301/tj.5000532",

language = "English",

volume = "103",

pages = "114--123",

journal = "Tumori",

issn = "0300-8916",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - External beam radiotherapy in thyroid carcinoma

T2 - Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group

AU - Mangoni, Monica

AU - Gobitti, Carlo

AU - Autorino, Rosa

AU - Cerizza, Lorenzo

AU - Furlan, Carlo

AU - Mazzarotto, Renzo

AU - Monari, Fabio

AU - Simontacchi, Gabriele

AU - Vianello, Federica

AU - Basso, Michela

AU - Rambaldi, Giuseppe Zanirato

AU - Russi, Elvio

AU - Tagliaferri, Luca

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the "Radioterapia Metabolica" Group of the Italian Radiation Oncology Association.

AB - The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the "Radioterapia Metabolica" Group of the Italian Radiation Oncology Association.

KW - Anaplastic thyroid carcinoma

KW - External beam radiotherapy

KW - Follicular thyroid carcinoma

KW - Medullary thyroid carcinoma

KW - Papillary thyroid carcinoma

KW - Radiometabolic therapy

UR - http://www.scopus.com/inward/record.url?scp=85016196360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016196360&partnerID=8YFLogxK

U2 - 10.5301/tj.5000532

DO - 10.5301/tj.5000532

M3 - Review article

C2 - 27647221

AN - SCOPUS:85016196360

VL - 103

SP - 114

EP - 123

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -